Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Abdullah H Baqui a Department of International
Health, Johns Hopkins Bloomberg School of Public Heath, 615 N Wolfe
Street, Baltimore, MD 21205, USA, b Department of Population and Family
Health, Johns Hopkins Bloomberg School of Public Heath, c Child
Health Program, ICDDR,B: Centre for Health and Population Research, GPO
Box 128, Dhaka 1000, Bangladesh, d Matlab Health Research Program, ICDDR,B:
Centre for Health and Population Research, e London School of Hygiene and Tropical
Medicine, London WC1A 7HT
Correspondence to: A H Baqui
abaqui{at}jhsph.edu
Objective:
To evaluate the effect on morbidity and
mortality of providing daily zinc for 14 days to children with diarrhoea.
What is already known on this topic
Zinc supplements given during diarrhoea reduce the duration and
severity of treated episodes If given for 14 days during and after diarrhoea, zinc reduces the
incidence of diarrhoea and pneumonia in the subsequent two to three
months What this study adds
Zinc reduces admissions to hospital for diarrhoea The impact of zinc on mortality and morbidity can be achieved in a
realistic large scale public health programme
Design:
Cluster randomised comparison.
Setting:
Matlab field site of International Center for Diarrhoeal Disease Research, Bangladesh.
Participants:
8070 children aged 3-59 months
contributed 11 881 child years of observation during a two year period.
Intervention:
Children with diarrhoea in the
intervention clusters were treated with zinc (20 mg per day for 14 days); all children with diarrhoea were treated with oral rehydration therapy.
Main outcome measures:
Duration of episode of
diarrhoea, incidence of diarrhoea and acute lower respiratory
infections, admission to hospital for diarrhoea or acute lower
respiratory infections, and child mortality.
Results:
About 40% (399/1007) of diarrhoeal episodes were treated with zinc in the first four months of the trial; the rate
rose to 67% (350/526) in month 5 and to >80% (364/434) in month 7 and was sustained at that level. Children from the intervention cluster
received zinc for about seven days on average during each episode of
diarrhoea. They had a shorter duration (hazard ratio 0.76, 95%
confidence interval 0.65 to 0.90) and lower incidence of diarrhoea
(rate ratio 0.85, 0.76 to 0.96) than children in the comparison group.
Incidence of acute lower respiratory infection was reduced in the
intervention group but not in the comparison group. Admission to
hospital of children with diarrhoea was lower in the intervention group
than in the comparison group (0.76, 0.59 to 0.98). Admission for acute
lower respiratory infection was lower in the intervention group, but
this was not statistically significant (0.81, 0.53 to 1.23). The rate
of non-injury deaths in the intervention clusters was considerably
lower (0.49, 0.25 to 0.94).
Conclusions:
The lower rates of child morbidity and
mortality with zinc treatment represent substantial benefits from a
simple and inexpensive intervention that can be incorporated in
existing efforts to control diarrhoeal disease.
Zinc deficiency is highly prevalent in children in developing
countries
Zinc used as a treatment for diarrhoea reduces mortality in
children
Read all Rapid Responses